P-1808. Strategies for Antimicrobial Stewardship Program Resiliency During the COVID-19 Pandemic
Abstract Background The COVID-19 pandemic was an unprecedented stress test for hospital-based antimicrobial stewardship (AMS) programs. The purpose of this study was to characterize strategies for AMS program resiliency during the COVID-19 pandemic. Methods Using a national dataset, we identified hospitals according to three criteria: 1.) significant COVID-19 burden; 2.) appropriate antibiotic prescribing patterns before the pandemic; and 3.) maintenance of appropriate antibiotic prescribing patterns during the pandemic. We conducted semi-structured interviews with pharmacists, physicians and quality leaders involved in AMS during the pandemic from identified hospitals. Interview guides were developed using the Systems Engineering Initiative for Patient Safety (SEIPS) framework. Transcribed interviews were analyzed iteratively using content analysis directed by the SEIPS model. Results We conducted 30 interviews from 19 unique high-performing health care systems across the country. We interviewed 17 pharmacists, 12 physicians and 1 infection prevention nurse. Resilient AMS strategies in place pre-pandemic included positive hospital wide AMS culture (organization); system-wide AMS programs (organization); decentralized antimicrobial stewardship (organization); strong interprofessional relationships (organization & person); infectious disease involvement (person); protocols to facilitate pharmacist autonomy (organization & tools and technology) and automated tools to facilitate AMS program activities (tools and technology). Additionally, the following strategies were implemented during the pandemic to withstand increased workload and the rapidly evolving pandemic: prioritization of highest yield stewardship interventions (organization & task); and organizational flexibility (organization). Conclusion Using a systems engineering informed qualitative approach, we characterized work system strategies to promote resiliency among AMS programs during the COVID-19 pandemic which should inform future efforts to promote AMS program resiliency during periods of health system stress. Disclosures All Authors: No reported disclosures
Authors
- M. Pamela Griffin (ORCID: https://orcid.org/0009-0006-8016-5471)
- Rebecca J. Schwei (ORCID: https://orcid.org/0000-0002-6208-5703)
- Nicole E. Werner (ORCID: https://orcid.org/0000-0003-2363-9491)
- Michael S. Pulia (ORCID: https://orcid.org/0000-0001-5809-4060)
- Ashleen Kaur
- Lucas Schulz (ORCID: https://orcid.org/0000-0001-6587-5439)
- Aurora Pop‐Vicas (ORCID: https://orcid.org/0000-0001-6702-3328)
- Helena Ikenberry
- Sarah Scalzo
Institutions
- University of Wisconsin–Madison (US)
- UW Health University Hospital (US)
- Indiana University Bloomington (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1093/ofid/ofae631.1971
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00